"pancreatic ductaladenocarcinoma" trang 12 - tải miễn phí từ tailieuXANH
Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer

Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer
10    59    0
Preoperative maximum standardized uptake value and carbohydrate antigen 19– 9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma

Preoperative maximum standardized uptake value and carbohydrate antigen 19– 9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma
5    47    0
Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: A propensity score analysis

Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: A propensity score analysis
11    109    0
Overall survival in patients over 40 years old with surgically resected pancreatic carcinoma: A SEER-based nomogram analysis

Overall survival in patients over 40 years old with surgically resected pancreatic carcinoma: A SEER-based nomogram analysis
9    53    0
Comparative effectiveness of primary tumor resection in patients with stage III pancreatic adenocarcinoma

Comparative effectiveness of primary tumor resection in patients with stage III pancreatic adenocarcinoma
8    67    0
CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer

CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer
8    58    0
Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study
6    62    0
Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: A prospective, phase II, multicentre, single-arm study

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: A prospective, phase II, multicentre, single-arm study
7    61    0
IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer

IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer
11    124    0
Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial

Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial
9    58    0
The diversity between curatively resected pancreatic head and body-tail cancers based on the 8th edition of AJCC staging system: A multicenter cohort study

The diversity between curatively resected pancreatic head and body-tail cancers based on the 8th edition of AJCC staging system: A multicenter cohort study
11    62    0
Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment

Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment
8    66    0
Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma

Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma
6    66    0
Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer

Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer
8    63    0
Non-functional pancreatic neuroendocrine tumours: Emerging trends in incidence and mortality

Non-functional pancreatic neuroendocrine tumours: Emerging trends in incidence and mortality
10    49    0
Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: A case report and review of the literature

Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: A case report and review of the literature
5    48    0
Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis

Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
8    52    0
A prospective clinical and biological database for pancreatic adenocarcinoma: The BACAP cohort

A prospective clinical and biological database for pancreatic adenocarcinoma: The BACAP cohort
8    53    0
A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)

A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)
7    58    0
Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC

Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC
10    52    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.